1
0
0
News
Good News for Pulmonary Disease Patients - ChemistryViews
www.chemistryviews.org
Selective and potent human neutrophil elastase inhibitor for pulmonary diseases
Netzwerk-Profile
LinkedIn: Adrian Tersteegen | LinkedIn
Adrian Tersteegens berufliches Profil anzeigen LinkedIn ist das weltweit größte ... Netzwerk, das Fach- und Führungskräften wie Adrian Tersteegen dabei hilft, ...
LinkedIn: Adrian Tersteegen - Deutschland | LinkedIn
Sehen Sie sich das Karriere-Profil von Adrian Tersteegen (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- ...
Business-Profile
patentbuddy: Adrian Tersteegen
AICURIS GMBH & CO. KG, Velbert, DE
Besitz
US SUBSTITUTED PHENYLALANINE DERIVATIVES
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Bücher
AACR Proceedings: Abstracts American Association for...
books.google.lu
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their...
Anabole Reaktionen mit Standardpotentialen - Adrian Tersteegen -...
books.google.de
Adrian Tersteegen pages. 0 Reviewshttp://books.google.com/books/about/Anabole_Reaktionen_mit_Standardpotential.html?id=kMV9MgAACAAJ ...
Dokumente zum Namen
US A1
patentimages.storage.googleapis.com
29. ruj — Adrian TERSTEEGEN, Wuppertal. (DE); Kristin BEYER, Kensington, CA. (US); Martina SCHAFER, Berlin. (DE); Anja BUCHMULLER, Essen. › ...
(11) PL/EP PL /EP T3 - Wyszukiwarka Urzędu ...
grab.uprp.pl
ADRIAN TERSTEEGEN, Wuppertal, DE. DMITRY ZUBOV, Remscheid, DE. REIMUND KAST, Wuppertal, DE. JENS SCHAMBERGER, Velbert - Langenberg, DE.
Curriculum vitaemc.minia.edu.eg MN-FPHA-TOXI-ASHRAF%20AB...
mc.minia.edu.eg
Rothkegel, Adrian Tersteegen, Barbara Kemp-Harper, Werner Müller-Esterl and Harald H.H.W. Schmidt. "Targeting the heme-oxidized nitric oxide receptors for ...
Untitledcontent.globalinnovationcommons.org/pdf.../US p...
content.globalinnovationcommons.org
Adrian Tersteegen, Wuppertal. (DE); Michael Gerisch, Wuppertal. (DE). Publication Classification. (51) Int. Cl. A61K ( ). C07D ( ).
Wissenschaftliche Veröffentlichungen
masp inhibitory compounds and uses thereof - Justia Patents
patents.justia.com
12. kol — ... Ingo FLAMME (Reichshof), Dmitry ZUBOV (Remscheid), Thomas NEUBAUER (Wuppertal), Adrian TERSTEEGEN (Wuppertal), Cathleen JUHL (Hamburg), ... › patent
BMC Pharmacology | 2nd international conference of cGMP generators,...
preview-bmcpharma.biomedcentral.com
BMC Pharmacology is an open access journal publishing original peer-reviewed research articles in aspects of the discovery, design, uses, effects, modes of ...
Verfasser Suchresultate :: Katalog der Universitätsbibliothek Leipzig
katalog.ub.uni-leipzig.de
Treffer von 7 für Suche: 'Adrian Tersteegen'. Sortieren. Relevanz, Erscheinungsjahr, absteigend, Erscheinungsjahr, aufsteigend, Person / Institution, Titel ...
US Patent Application for INHIBITION OF PDE2A Patent Application...
patents.justia.com
Inventors: Peter Ellinghaus (Wuppertal), Andreas Wilmen (Koln), Martin Hendrix (Odenthal), Adrian Tersteegen (Wuppertal) Application Serial: ...
Veröffentlichungen allgemein
Characterization of the novel PDE9 inhibitor BAY using a cGMP...
bmcpharma.biomedcentral.com.preview-live.oscarjournals.springer.com
Frank WunderEmail author,; Adrian Tersteegen and; Martin Hendrix. BMC Pharmacology20055(Suppl 1):P64. DOI: S
Sonstiges
Adrian Tersteegen | LinkedIn
www.linkedin.com
View Adrian Tersteegen's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Adrian Tersteegen ...
Es fehlt: ostelsheim
Adrian Tersteegen, Wuppertal DE - Patent applications
www.patentsencyclopedia.com
Patent application number, Description, Published , Cyanopyrimidinones - The invention relates to novel cyanopyrimidinones, process for their ...
Adrian Tersteegen
www.infona.pl
Adrian Tersteegen. Details · Publications ... Heather Thompson, Adrian Tersteegen, Rudolf K. Thauer, R. Hedderich · Archives of Microbiology 170 , 1.
cGMP 2nd International Conference Program
www.cyclicgmp.net
2nd International Conference on cGMP cGMP: Generators and Effectors
(11) PL/EP PL/EP T3 - Urząd Patentowy ...
pubserv.uprp.pl
ADRIAN TERSTEEGEN, Wuppertal, DE. JOACHIM KRÜGER, Düsseldorf, DE. HOLGER PAULSEN, Hilden, DE. (74) Pełnomocnik: rzecz. pat.
BENZYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF - Patent...
www.patentsencyclopedia.com
... information provided by MapQuest, OpenStreetMap and contributors, CC-BY-SA. Patent applications by Adrian Tersteegen, Wuppertal DE.
Altmetric – The novel selective PDE9 inhibitor BAY improves...
www.altmetric.com
F. Josef van der Staay, Kris Rutten, Lars Bärfacker, Jean DeVry, Christina Erb, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Marja van Kampen, Arjan ...
Characterization of the first potent and selective PDE9 inhibitor...
molpharm.aspetjournals.org
Frank Wunder, Adrian Tersteegen, Annegret Rebmann, Christina Erb, Thomas Fahrig and Martin Hendrix. Molecular Pharmacology September ...
Expression and Function of Soluble Guanylate Cyclase in ...
ersj.org.uk
Adrian Tersteegen for performing the PDE assays, Ewa Bieniek for the immunohisto- chemistry and Andreas Hecker for performing the acute ...
CSHL Meetings
meetings.cshl.edu
Cold Spring Harbor Meetings and Courses - Long Island, New York. Scientific Conferences and Courses For Research and Education
Targeting the heme-oxidized nitric oxide receptor for selective...
www.ncbi.nlm.nih.gov
Adrian Tersteegen is currently employed by Bayer HealthCare. Harald H.H.W. Schmidt is coinventor of a patent on the use of human sGC, owned by vasopharm ...
Characterization of the Cellular Activity of PDE 4 Inhibitors Using...
www.bionity.com
We report here the generation and pharmacological characterization of two novel PDE 4B1 and PDE 4D3 reporter cell lines. Intracellular cAMP levels are...
Characterization of the cellular activity of PDE 4 inhibitors using...
read.qxmd.com
Frank Wunder, Ramona Quednau, Andreas Geerts, Martina Barg, Adrian Tersteegen. Molecular Pharmaceutics October 7, 10 (10):
Most Accessed Articles: June ChemistryViews
www.chemistryviews.org
The most-accessed chemistry articles from ChemPubSoc Europe, ACES, and GDCh journals for June 2015
Untitled Page
www.gccpo.org
[73] Owner: PFIZER INC., USA. [74] Agent: Kadasa Law Firm. [56] Cited Documents: FRANK WUNDER, ADRIAN TERSTEEGEN, ANNEGRET
it-app.dziv.hr
Uwe SaatmannWuppertal, DE Adrian Tersteegen Wuppertal, DE Joachim Krüger, Zeppenheimer ...
Synthesis and alkyne coordination chemistry of thiacycloalkynes
www.infona.pl
Francesca M. Kerton G. Farouq Mohmand Adrian Tersteegen Markus Thiel Michael J. Went. Treść / Zawartość. main.pdf. Abstrakt, słowa kluczowe. Źródło.
Verwandte Suchanfragen zu Adrian Tersteegen
| Heather Thompson Martin Hendrix Gabi Tersteegen |
Personen Vorname "Adrian" (15135) Name "Tersteegen" (107) |
sortiert nach Relevanz / Datum